Lung Carcinoma Clinical Trials
25 studies are recruiting for lung carcinoma in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies now recruiting
-
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
This clinical trial develops and studies whether a restorative justice-based lung cancer screening (LCS) decision-making support intervention tailored for Black individuals increases LCS among Black community members. Lung cancer remains the leading cause of cancer deaths among Black men and women.…
- Stage
- Not phased
- Ages
- 50 to 77
- Site
- Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
- Run by
- Fred Hutchinson Cancer Center
-
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
This clinical trial studies whether tailored patient navigation (PN) works to improve the uptake of lung cancer screening (LCS) in tribal communities in western Washington state. Lung cancer is the leading cause of cancer death in the United States among American Indian (AI) and Alaska Native (AN) …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Muckleshoot Tribal Clinic, Auburn, Washington
- Locations
- 2 in total
- Run by
- Fred Hutchinson Cancer Center
-
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
This phase II trial tests how well fucoidan works in preventing chemotherapy-related fatigue compared to a placebo in patients with gastrointestinal (GI), gynecological (GYN), breast, or lung cancer. Fatigue poses a burden in patients with malignancies undergoing systemic chemotherapy. Fucoidan is …
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Mayo Clinic in Arizona, Scottsdale, Arizona
- Run by
- Mayo Clinic
-
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
This clinical trial evaluates the acceptability and effectiveness of an educational intervention (Lung Toolkit) for improving knowledge about lung cancer and lung cancer screening among American Indian/Alaskan Native (AI/AN) cigarette smokers. The Lung Toolkit is an educational intervention, includ…
- Stage
- Not phased
- Ages
- 50 to 80
- Site
- Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
- Run by
- Fred Hutchinson Cancer Center
-
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
This clinical trial evaluates the relationship between walking and sleeping habits and surgical outcomes in patients with lung cancer. Early walking after surgery is associated with decreased or less severe complications. Learning about how much patients walk may be important in improving outcomes …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- M D Anderson Cancer Center, Houston, Texas
- Run by
- M.D. Anderson Cancer Center
-
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
This clinical trial compares the use of a new screening tool designed to evaluate patients' information needs, preferences, and illness understanding to the usual care to improve illness understanding in patients with lung cancer that has spread from where it first started (primary site) to other p…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- MD Anderson Cancer Center, Houston, Texas
- Run by
- M.D. Anderson Cancer Center
-
Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
This implementation study will examine the best ways to refer heavy smokers to information about lung cancer screening.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- M D Anderson Cancer Center, Houston, Texas
- Run by
- M.D. Anderson Cancer Center
-
The Vanguard Study: Testing a New Way to Screen for Cancer
The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously. There is a need to understand h…
- Stage
- Not phased
- Ages
- 45 to 75
- Site
- Kaiser Permanente-Division of Research, Pleasanton, California
- Locations
- 45 in total
- Run by
- National Cancer Institute (NCI)
-
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
This phase I/II trial studies the best dose and timing of panitumumab-IRDye800 in detecting cancer in participants with lung cancer during the surgery. Panitumumab-IRDye800 is a combination of the antibody drug panitumumab and IRDye800CW, an investigational dye that can be seen using a special came…
- Stage
- Phase 1
- Ages
- 19 and older
- Site
- Stanford University, School of Medicine, Palo Alto, California
- Run by
- Stanford University
-
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
This phase II trial studies whether providing cancer treatment in the home is preferred over the traditional clinic setting and if it improves treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas. Typically, drug-related cancer care is provided at a medica…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Mayo Clinic in Florida, Jacksonville, Florida
- Run by
- Mayo Clinic
-
The Rise in Robotic Atypical Segmentectomies
This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.
- Stage
- Not phased
- Ages
- Any age
- Site
- M D Anderson Cancer Center, Houston, Texas
- Run by
- M.D. Anderson Cancer Center
-
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care
This study evaluates the effectiveness of tumor samples in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic in Rochester, Rochester, Minnesota
- Run by
- Mayo Clinic
-
Patient-Derived Xenografts to Reduce Cancer Health Disparities
This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of the…
- Stage
- Not phased
- Ages
- 21 to 100
- Site
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California
- Locations
- 2 in total
- Run by
- University of California, Davis
-
Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
This pilot phase I/II trial studies how well a continuous positive airway pressure device or deep inspiration breath hold works in reducing tumor movement in patients undergoing stereotactic body radiation therapy (SBRT) for lung cancer. The continuous positive airway pressure device works by blowi…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- M D Anderson Cancer Center, Houston, Texas
- Run by
- M.D. Anderson Cancer Center
-
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
This study evaluates how useful and acceptable the components of the "Couples Coping Together Against Cancer", referred to as "The Program", are to the participants with cancer.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- City of Hope Medical Center, Duarte, California
- Run by
- City of Hope Medical Center
-
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- M D Anderson Cancer Center, Houston, Texas
- Run by
- M.D. Anderson Cancer Center
-
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
This phase II trial studies the effects of canakinumab in preventing lung cancer in patients who have high-risk pulmonary nodules. Canakinumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Giving canakinumab may prevent the development of lung cance…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- M D Anderson Cancer Center, Houston, Texas
- Run by
- M.D. Anderson Cancer Center
-
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
This clinical trial tests how well providing education improves screening for lung cancer in patients with a history of smoking. Screenings may help doctors find lung cancer sooner when it may be easier to treat. Education and counseling may be an effective method to help providers and patients lea…
- Stage
- Not phased
- Ages
- 50 to 77
- Site
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania
- Run by
- Ronald Myers
-
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
This phase II trial tests the effectiveness and safety of artificial intelligence (AI) to determine dose recommendation during stereotactic body radiation therapy (SBRT) planning in patients with primary lung cancer or tumors that has spread from another primary site to the lung (metastatic). SBRT …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Northwestern University, Chicago, Illinois
- Run by
- Northwestern University
-
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
This clinical trial compares telephone-based physical activity coaching to self monitored physical activity for improving physical function in older adults who are undergoing surgery for lung cancer and their caregivers. Lung cancer surgery in older adults is associated with functional declines and…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of California, Davis, California
- Locations
- 16 in total
- Run by
- City of Hope Medical Center
-
Engagement of Veterans With Lung Cancer
This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto, California
- Run by
- Palo Alto Veterans Institute for Research
-
Lung Cancer Screening in High-risk Black Individuals
The goal of this research study is to study U.S. Black individuals with a history of smoking to examine the feasibility, acceptability, and performance of low-dose computed tomography (LDCT) screening among this population. The name of the intervention used in this research study is: Low-dose compu…
- Stage
- Not phased
- Ages
- 50 to 80
- Site
- University of Chicago, Chicago, Illinois
- Locations
- 2 in total
- Run by
- Massachusetts General Hospital
-
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
This clinical trial examines positron emission tomography (PET)/computed tomography (CT) in evaluating cardiac radiation damage in patients with lung or esophageal cancer. As part of the treatment for lung or esophageal cancer, patients will undergo radiation therapy. Sometimes, during this treatme…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
- Run by
- Thomas Jefferson University
-
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
- Run by
- University of Michigan Rogel Cancer Center
-
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely ac…
- Stage
- Not phased
- Ages
- 40 to 80
- Site
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
- Run by
- Jonsson Comprehensive Cancer Center
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.